SPECIALTY TOPICS

CURRENTLY VIEWING
All Specialties

Search Videos by Topic or Participant

A unqiue opportunity to view lively discussions featuring peer-to-peer exchanges that provide authoritative insights, opinions, and perspectives on important issues facing today's cancer care professionals.

Select Topic:

Browse by Series:

Global Outlook on Advanced Nonsquamous NSCLC

Emerging Therapies for Nonsquamous NSCLC

Consolidation Immunotherapy for Locally Advanced NSCLC

NSCLC: Promising Molecular Targets

Changing Treatment Paradigm for BRAF-Mutant NSCLC

Second-Line Brigatinib for ALK-Rearranged NSCLC

ALEX Trial: Frontline Therapy for ALK-Rearranged NSCLC

Upfront Therapy for ALK/ROS1-Rearranged NSCLC

EGFR-Positive NSCLC: Treatment at Progression

Managing CNS Metastases in EGFR-Positive NSCLC

Next Page >>

Featured

The Evolving Landscape of Immunotherapy for NSCLC

A video editorial series that features expert opinions on multiple areas of focus.

View more >>>

Featured

FDA Approves Blinatumomab for MRD+ ALL

The FDA has granted an accelerated approval to blinatumomab for the treatment of adult and pediatric patients with B-cell precursor acute lymphoblastic leukemia who are in remission but still have minimal residual disease.

View more >>>

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approvals in RCC and Chronic ITP, 2018 ELCC Highlights, and More